Researchers found that lenacapavir reduced almost 100% reduction new HIV infections among participants who received it as a ...

Thousands of adults age 50-plus are diagnosed with HIV every year, but an expanding menu of medications can help prevent ...

At the University of the Witwatersrand, scientists are developing HIV vaccines that could help change the course of the ...

According to experts at the IAS 2025 meeting in Kigali, Rwanda, AI revolutionizes HIV vaccine development by enhancing design ...

A monthly pill would add to the growing number of choices for HIV preexposure prophylaxis, which is now seen as the best hope ...

In recent months, reports of rising HIV infections in Malaysia have once again made national headlines. The data paints a ...

Gilead's Papao shares insights on the evolving role of public-private collaboration in healthcare, and how emerging tech is ...

A local psychedelics campaign by public health advocates is focusing on health and safety. As Colorado begins to allow ...

A new study aims to help healthcare providers more effectively implement Apretude, a medication used for HIV prevention.

KINSHASA, Democratic Republic of the Congo, July 19, 2025/APO Group/ -- Mpox continues to strain the Democratic Republic of the Congo's health sys ...

Researchers from the UC Irvine Joe C. Wen School of Population & Public Health found that more than 70% of transgender women ...

Bello, a professor of obstetrics and gynaecology and the HPV Consortium Project Directorate at the College of Medicine of the ...